Biotage

Biotage ROE

Delisted

The Return on Equity (ROE) of Biotage (BIOT.ST) as of Oct 20, 2026 is 6.90 %. In the previous year, Return on Equity (ROE) was 6.73 % — a change of 2.65% (higher).

ROE

6.90 %

YoY

2.65%

Last updated:

In 2024, Biotage's return on equity (ROE) was 6.90 %, a 2.65% increase from the 6.73 % ROE in the previous year.

The Biotage ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
22.80 SEK
Jan 1, 2018
23.87 SEK
Jan 1, 2019
21.34 SEK
Jan 1, 2020
17.68 SEK
Jan 1, 2021
14.94 SEK
Jan 1, 2022
16.37 SEK
Jan 1, 2023
6.73 SEK
Jan 1, 2024
6.90 SEK
The Biotage ROE history
YEARROEYoY
6.90 %+2.65%
6.73 %-58.91%
16.37 %+9.57%
14.94 %-15.47%
17.68 %-17.16%
21.34 %-10.61%
23.87 %+4.72%
22.80 %+38.37%
16.48 %+22.95%
13.40 %+31.78%
10.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

ROE Details

Decoding Biotage's Return on Equity (ROE)

Biotage's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Biotage's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Biotage's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Biotage’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Biotage stock

Return on Equity (ROE) of Biotage is 6.90 % in 2024.

Return on Equity (ROE) of Biotage changed from 6.73 % to 6.90 %, representing a 2.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Biotage since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Biotage with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Biotage

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Biotage